Abstract
Objective: Investigation of pharmacokinetics parameters of the new silver-based compound of general formula C6H19Ag2N4LiO6S2, called “Argosil”, with high antiviral activity. Methods: Water solution of complex administered intragastrically in the dose rate of 100 mg/kg body weight of mice BALB/c (males) aged 1.5-2.0 mo. Blood and tissues samples analyzed by mass spectrometry. Results: Half-life of the drug was about 4 h at the initial stage. About 5% of the initially introduced silver detected after 24 h. Maximum drug concentration observed in the lung tissues. Conclusion: Results make the basis for further test and clinical implementation. Taken into account low toxicity and antiviral properties of this compound, it looks especially effective for lung infections treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 41-43 |
| Number of pages | 3 |
| Journal | International Journal of Pharmacy and Pharmaceutical Sciences |
| Volume | 7 |
| Issue number | 6 |
| Publication status | Published - 2015 |
Keywords
- Antiviral drug
- Argosil
- Mass spectrometry
- Pharmacokinetics
- Silver distribution in tissues
- Silver-based complex
ASJC Scopus subject areas
- Pharmaceutical Science
- Pharmacology